The traceability matrix of changeset #15 to SOP-FIL-007, aseptic filling on Line 2, version v12 to v13: each requirement with its risk, where it is configured and the test cases that verify it. URS-FIL-01: Signed by trained operators. Step 4.1, high risk, verified by TC-03 and TC-08. URS-FIL-02: Fill weight in limits. Step 4.2, high risk, verified by TC-03 and TC-05. URS-FIL-03: Weights read, never typed. Step 4.2, high risk, verified by TC-03. URS-FIL-04: Balance in calibration. Step 4.2, medium risk, verified by TC-03. URS-FIL-05: Bowl check every hour, was every 2 hours. Step 4.3, medium risk, verified by TC-01 and TC-02. URS-FIL-06: Restart rejects open vials. Step 4.4, high risk, verified by TC-04. URS-FIL-07: A lot keeps its version. Versions, medium risk, verified by TC-06 and TC-07. URS-FIL-08: Version in the audit trail. Audit trail, high risk, verified by TC-09. URS-FIL-09: Jam recorded before restart. Step 4.3, high risk, verified by TC-10, TC-11 and TC-12. The change touches step 4.3 and 2 of the 9 requirements: the bowl check goes from every 2 hours to every hour, and a jam cleared as INT-07 and recorded before the line restarts is new. The 9 standing test cases Blubber's Validation wrote for go-live are reused and run again; 3 new ones, drafted by Neil at 09:31, verify the new requirement and were approved by R. Haldane in Validation at 09:52, before any case ran. All 12 test cases passed on v13 at 09:54. K. Brandt signed for Production at 10:40 and S. Amato approved it for QA at 11:20. v13 took effect at 21:34, once the night shift was trained, and lots made on v12 keep v12.
SOP-FIL-007 › Changeset #15 › Traceability
Effective 21:34
Line 2v13
Aseptic filling
RequirementWhereRisk9 standing3 new
2 of 9 requirements touched
9 standing cases reused
3 new
12 of 12 test cases passed
Assurance record
Tue 10 Nov
Approved at 11:20, effective at 21:34. Lots made on v12 keep v12Step 4.1: everyone who signs is trained on the version in force. Verified by TC‑03 and TC‑08Step 4.2: each pump's mean of 5 vials, 10.00 to 10.40 g, every 30 min. Verified by TC‑03 and TC‑05Step 4.2: each weighing read from B‑04 by Seal Edge; none typed. Verified by TC‑03Step 4.2: b‑04's calibration checked at each weighing, due 3 Dec. Verified by TC‑03Step 4.3, changed in v13: bowl check every hour during filling, was every 2 hours. Verified by TC‑01 and TC‑02Step 4.4: after a stop, the open vials in the zone are rejected. Verified by TC‑04Versions: a lot keeps the version it was made on; a new lot opens on the one in force. Verified by TC‑06 and TC‑07Audit trail: each entry names its version, who, when and why. Verified by TC‑09Step 4.3, new in v13: a jam cleared as INT‑07 and recorded before the line restarts. Verified by TC‑10, TC‑11 and TC‑12TC‑01 The check falls due after 60 min. Standing since go‑live on 22 Sep, for any change to a stepTC‑02 An overdue check is flagged on the record. Standing since go‑live on 22 Sep, for any change to a stepTC‑03 Steps 4.1 and 4.2 are unchanged. Standing since go‑live on 22 Sep, for any change to a stepTC‑04 Steps from 4.4 on are unchanged. Standing since go‑live on 22 Sep, for any change to a stepTC‑05 Fill weight limits are unchanged. Standing since go‑live on 22 Sep, for any change to a stepTC‑06 Lot 26‑0917's record stays on v12. Standing since go‑live on 22 Sep, for any change to a stepTC‑07 The next fill starts on v13. Standing since go‑live on 22 Sep, for any change to a stepTC‑08 An untrained operator is flagged at 4.3. Standing since go‑live on 22 Sep, for any change to a stepTC‑09 The audit trail records both versions. Standing since go‑live on 22 Sep, for any change to a stepTC‑10 Clearing a jam needs a recorded intervention. Drafted by Neil at 09:31; R. Haldane approved it at 09:52TC‑11 Its start, end and rejected vials are required. Drafted by Neil at 09:31; R. Haldane approved it at 09:52TC‑12 A stop over 10 min opens a deviation for QA. Drafted by Neil at 09:31; R. Haldane approved it at 09:52DEV‑041's review, 09:00 to 09:30: an hourly bowl check, and a jam recorded before restartDrafted by Neil from the review's decision. Clearing a jam is still INT‑07, so no new media fillDrafted by Neil for Validation and QA: URS‑FIL‑05 changes, URS‑FIL‑09 is new and rated highDrafted by Neil for QA: no other step changes. Written for go‑live on 22 Sep, for any change to a stepPassword and authenticator code. A person approves the cases Neil drafted before they runRun before Production and QA signed: the 3 new cases first, then the 9 standingMeaning: reviewed. Password and authenticator code, 10 Nov 10:40 GMTPassword and authenticator code, 10 Nov 11:20 GMT. Training assigned to Line 2's 11 operatorsIn force once the night shift was trained, 4 of 4. Lot 26‑0917, made on v12, stays on it
Blubber Biologics is a fictional plant. Seal’s own evidence for your review is below.
Every record.Its full history.
Each record keeps its audit history and electronic signatures, with controls to support 21 CFR Part 11 and EU GMP Annex 11.
Step 9.4 of lot 26-0917's batch record, certification, on Monday 23 November 2026. E. Marchetti, Blubber Biologics' Qualified Person, re-entered their password and authenticator code and signed at 10:12 GMT with the meaning certified and released, 17 days after the lot's fill on Friday 6 November. The signature shows the signer's printed name and role, the date and time with its zone, its meaning and how it was made, as 21 CFR 11.50 asks, and what it is linked to, as 11.70 asks: lot 26-0917's batch record as it stood, 8 of 8 steps signed and 1,912 entries, 50 checks confirmed by QA and 7 decided, 19 of 19 results in and deviation DEV-041 closed. Beside it, the lines of the record's audit trail that matter, oldest first. On Wednesday 4 November at 10:12 T. Nowak typed step 1.6's drug substance weight as 21.02 kg, and at 10:26 changed it to 21.20 kg with the reason “typo”; 21.02 kg is kept, struck through. On Monday 9 November at 11:46 L. Haddad's endotoxin run was invalid, and the invalid run stays on the lot; the last production signature came at 17:58, with 8 of 8 steps signed. Neil's record review was ready on Tuesday 10 November at 00:18 with seven things for QA to decide: a draft, not a signature. S. Amato of QA opened deviation DEV-041 at 08:30, and H. Tanaka, the QC manager, approved the invalid run's assessment that day. On Friday 13 November QA accepted the bulk hold and the endotoxin retest passed. The sterility result came in on Friday 20 November, 19 of 19 results, and S. Amato closed DEV-041 the same day. The last line is the certification, on Monday 23 November at 10:12. A later correction is a dated late entry, never overwritten, and the signature records the version signed.
Lot 26-0917 › Batch record › Certification
Certified 10:12
Certification Step 9.4
Filled Fri 6 Nov on Line 2
Signature21 CFR 11.50
What it signs11.70
A later correction
From its audit trailOldest first
Step 9.4: the QP certifies on 19 of 19 results, every deviation closed and the record reviewedE. Marchetti re-entered their password and authenticator code to signThe meaning is signed with the name and the timeThe signature keeps its signer, time and meaning, linked to the recordThe original entry stands, with the correction beside it, as step 1.6's weight doesCertified at 10:12 on the record as it stood, beside the history that led to itBlubber Biologics' Qualified Person, who certifies the lotThe lot's disposition. At 10:14 order SO-1182 takes 40,000 of its vialsWith its zone. 17 days after the fill on Fri 6 Nov, 14 of them the sterility testBoth entered for this signatureAs it stood at 10:12. Step 9.4 of the lot's record: the signature is linked to itLast production signature Mon 9 Nov 17:58Blubber's checklist RC-014 v6. Neil drafted; QA confirmed each check and decided the sevenSterility read Fri 20 Nov; S. Amato closed DEV-041 the same dayAs the records of lots 26-0912 and 26-0914 were corrected on Fri 13 NovIts signer, time and meaning stay linked to the record it signedThe drug substance, typed from floor scale FS-11, which isn't connected. Replaced at 10:26, and kept21.02 kg is kept, with who changed it, when and why. Neil's review cited it to QA as check C-17Run R-1005-02: spike recovery 31%, limit 50 to 200%. The invalid run stays on the lotPack, the last production step. The record then held 1,912 entries1,912 entries read against checklist RC-014 v6, 45 of 50 met. For QA, not a signatureFrom Neil's draft of Mon 20:10: the 21 min stop the record left outThe QC manager. The product inhibited the test, so the retest is at a further dilution29 h 40 min, past study EXP-332's 26 h. Assessed in DEV-041: bioburden 0 CFU in 100 mLAt most 0.5 EU/mL, by method QCM-031 v4. The 18th of the 19 results14 days' incubation from the fill. The last of the 19 resultsAfter the sterility result. The four earlier lots were assessed Fri 13 Nov: no product impactStep 9.4. Meaning: certified and released. Password and authenticator codeCertified
“…seeking improved administrative efficiency, electronic signatures and audit trails. Seal ticked all these boxes.”
Under Seal’s agreements, your data is not used to train the underlying AI models. Neil decides nothing in GMP work.
What Seal keeps with one finding of Neil's, in the five parts a reviewer asks for. Asked: the record review of lot 26-0917, which started on the lot's last production signature at 17:58 on Monday 9 November, a job on Line 2 that Blubber's Validation and QA approved on Friday 6 November, reading against Blubber's checklist RC-014 v6 and only what Blubber connected, with the access it was given. Read: the batch record as it stood at 17:58, 1,912 entries; F-02's readings for the fill on Friday 6 November, 00:20 to 10:00, by Seal Edge; and Line 2's shift channel and handovers, 653 messages, not private chats or mail. Wrote, at 19:40: “Line 2 stopped 21 min; the record says no interventions”, kept as written, not a later rerun, citing step 4.3, F-02's readings and the channel. It is drawn on one clock, the fill from 01:30 to 03:30: the batch record has fill weight checks signed at 02:07 and 02:37 and nothing between them, and step 4.3 says “No interventions”; F-02's feed track current is 0 A from 02:08 to 02:29; and at 02:11 the night shift wrote “Stopper bowl jammed again” in Line 2's channel. Proposed: deviation DEV-041, drafted on Blubber's form for QA to decide at 20:10; Neil opened nothing itself. Decided: S. Amato of QA opened DEV-041 on Tuesday 10 November at 08:30, signed with password and authenticator code. QA decides each finding; Neil decides nothing in GMP work.
Neil › Record review, Line 2 › The 21 min stop
Decided by QA
Lot 26‑0917Outside the checklist
“Line 2 stopped 21 min; the record says no interventions”
Found by Neil, Mon 9 Nov 19:40
Fri 6 Nov, the fill
02:0702:37
01:3002:0002:3003:0003:30
Neil read only what Blubber connected, with the job's access
Kept with the finding
Tue 08:30
What Neil was asked, read, wrote and proposed, kept with the person who decidedLine 2's job, read against Blubber's checklist RC‑014 v6. Approved by R. Haldane and S. Amato, Fri 6 NovThe readings by Seal Edge, kept on the lot's record. Line 2's channel in Teams, not private chats or mailA citation helps QA inspect the evidence. It does not prove the interpretationOne of seven in the record review's brief, ready for QA Tue 00:18Decided from the sources the finding cites. DEV‑041's review followed at 09:00Fill weights signed every 30 min. Step 4.3 signed as it closed, Fri 6 Nov 10:00Read each second by Seal Edge on EDGE‑L2 over OPC UA, read-only, kept on each lot's recordA message in Line 2's shift channel, which Blubber connected. The channel is not the record
Seal provides the platform controls, its assurance capabilities and the supplier evidence for the version in scope. Your team owns the intended use, risk acceptance and production approval.
To software used in medical-device production and quality management systems. FDA’s guidance, final in February 2026, supports proportionate assurance, including automated and unscripted testing where appropriate to the risk.
No. Selected UATs run when a change is prepared for review. Your team still reviews the acceptance criteria and the results, and approves the intended use.
Who created or changed each record and when, signatures that show the signer’s printed name, the date and time and the meaning (21 CFR 11.50), and signatures linked to their records (11.70).
The draft, published for consultation in July 2025 and not yet adopted, says large language models should not be used in critical GMP applications. Neil decides nothing in GMP work: it helps set up configuration that your team verifies and releases under change control, and what it flags or drafts a qualified person reviews and signs.